Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOFLOXACIN Cause Benign prostatic hyperplasia? 137 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Benign prostatic hyperplasia have been filed in association with LEVOFLOXACIN (Levofloxacin). This represents 0.3% of all adverse event reports for LEVOFLOXACIN.

137
Reports of Benign prostatic hyperplasia with LEVOFLOXACIN
0.3%
of all LEVOFLOXACIN reports
2
Deaths
119
Hospitalizations

How Dangerous Is Benign prostatic hyperplasia From LEVOFLOXACIN?

Of the 137 reports, 2 (1.5%) resulted in death, 119 (86.9%) required hospitalization, and 7 (5.1%) were considered life-threatening.

Is Benign prostatic hyperplasia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOFLOXACIN. However, 137 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOFLOXACIN Cause?

Drug hypersensitivity (3,660) Neuropathy peripheral (2,619) Arthralgia (2,594) Pain in extremity (2,317) Pain (2,266) Drug ineffective (2,181) Dyspnoea (2,074) Tendonitis (1,813) Aortic aneurysm (1,767) Nausea (1,694)

What Other Drugs Cause Benign prostatic hyperplasia?

TADALAFIL (596) TAMSULOSIN (304) FINASTERIDE (266) PANTOPRAZOLE (261) PREDNISONE (257) ALBUTEROL (254) ASPIRIN (243) TIOTROPIUM (235) RAMIPRIL (193) AMLODIPINE (179)

Which LEVOFLOXACIN Alternatives Have Lower Benign prostatic hyperplasia Risk?

LEVOFLOXACIN vs LEVOKETOCONAZOLE LEVOFLOXACIN vs LEVOLEUCOVORIN LEVOFLOXACIN vs LEVOMEPROMAZINE LEVOFLOXACIN vs LEVOMETHADONE LEVOFLOXACIN vs LEVOMILNACIPRAN

Related Pages

LEVOFLOXACIN Full Profile All Benign prostatic hyperplasia Reports All Drugs Causing Benign prostatic hyperplasia LEVOFLOXACIN Demographics